Compound 19e(Cardiff University )

Dual aromatase sulfatase inhibitors (DASIs) were developed from a common benzofuran pharmacophore resulting in potent low nanomolar inhibitors, which combined with molecular dynamics studies provided a clear rationale for the activity observed.